¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Stickler syndrome, type III"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • hemorrhagic fever with renal syndrome
    ÃâÇ÷¿­ÄáÆÏÁõÈıº, ÃâÇ÷¿­½ÅÁõÈıº
  • hepatorenal syndrome
    °£ÄáÆÏÁõÈıº
  • hand-foot syndrome
    ¼Õ¹ßÁõÈıº
  • hantavirus pulmonary syndrome
    ÇÑŸ¹ÙÀÌ·¯½ºÆóÁõÈıº
  • Horner¡¯s syndrome
    È£³ÊÁõÈıº
  • Hunter¡¯s syndrome
    ÇåÅÍÁõÈıº
  • Hurler¡¯s syndrome
    Çæ·¯ÁõÈıº
  • iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • irritable bowel syndrome
    °ú¹Î´ëÀåÁõÈıº
  • immotile cilia syndrome
    ºÎµ¿¼¶¸ðÁõÈıº
  • impingement syndrome
    ºÎµúÈûÁõÈıº, Ãæµ¹ÁõÈıº
  • idiopathic respiratory distress syndrome
    Ư¹ßÈ£Èí°ï¶õÁõÈıº
  • intracerebral steal syndrome
    ³ú³»Ç÷·ù»©¾Ñ±èÁõÈıº
  • Jadassohn-Lewandowsky syndrome
    ¾ß´Ù½ºÁ¸-·¹¹Ýµµºê½ºÅ°ÁõÈıº
  • jet lag syndrome
    ½ÃÂ÷ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • hunger pain syndrome
    °øº¹ÅëÁõÈıº
  • hyperstimulation syndrome
    °ú´ÙÀÚ±ØÁõÈıº
  • hyperventilation syndrome
    °ú´ÙÈ£ÈíÁõÈıº
  • hyperviscosity syndrome
    °ú´ÙÁ¡¼ºÁõÈıº
  • hypoventilation syndrome
    È£ÈíÀúÇÏÁõÈıº
  • idiopathic cramp syndrome
    Ư¹ß°æ·ÃÁõÈıº
  • idiopathic respiratory distress syndrome
    Ư¹ßÈ£Èí°ï¶õÁõÈıº
  • immersion foot syndrome
    ħ¼ö¹ßÁõÈıº, ¹ß´ã±ÝÁõÈıº
  • immune amnesia syndrome
    ¸é¿ª±â¾ï»ó½ÇÁõÈıº
  • immunoproliferative syndrome
    ¸é¿ª¼¼Æ÷Áõ½ÄÁõÈıº
  • impingement syndrome
    ºÎµúÈûÁõÈıº
  • infantile stiff skin syndrome
    ¿µ¾ÆÇǺΰæÁ÷ÁõÈıº
  • interosseous nerve syndrome
    »À»çÀ̽ŰæÁõÈıº, °ñ°£½Å°æÁõÈıº
  • intersection syndrome
    ±³Â÷ÁõÈıº
  • intracerebral steal syndrome
    ³ú³»Ç÷·ùÀúÇÏÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • Ganser syndrome
    °µ¼­ÁõÈıº.
  • Gardner s syndrome
    °¡¾Æµå³ÊÁõÈıº.
  • Gianotti-Crosti syndrome => infantile papular acrodermatitis
    Àð³ëƼ Å©·Î½ºÆ¼ ÁõÈıº
  • Gilberts syndrome
    Áúº£¸£ÁõÈıº
  • Glucose-galactose malabsorption syndrome
    ±Û·çÄÚ¿À½º-°¥¶ôÅ佺Èí¼öÀå¾ÖÁõÈıº(ýåâ¥î¡äôñøý¦ÏØ)
  • Goldenhars syndrome->oculo-auriculo-vertebral dysplasia
    °ñµçÇÏÁõÈıº
  • Goltzs syndrome => focal dermal hypoplasia
    ±¹¼Ò ÁøÇÇ Çü¼ººÎÀüÁõ
  • Golzs syndrome
    °ñÁî ÁõÈıº
  • Goodpasture s syndrome
    ±¸µåÆÐ½ºÃò¾î ÁõÈıº.
  • Gradenigos syndrome
    Ãßü(÷ºÎ)¿° ÁõÈıº, ±×¶óµ¥´Ï
  • Graham-Little syndrome
    ±×·¹À̾ö ¸®Æ² ÁõÈıº
  • Grey platelet syndrome
    ±×·¹ÀÌÇ÷¼ÒÆÇÁõÈıº
  • Guillain Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº.
  • Guillain-Barre syndrome
    ±æ¶û-¹Ù·¹ ÁõÈıº
  • HELLP syndrome
    HELLP ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • spinal type
    ô¼öÇü(ô±âÐúþ).
  • split electrode type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ
  • split-electrode-type probe
    ºÐÇÒ Àü±Ø ŽÃËÀÚ (ÝÂùÜ ï³Ð¿ ÷®õºí­)
  • sthenic type
    ±Ù·ÂÇü(ÐÉæ³úþ).
  • storage-type
    ÃàÀûÇü
  • supporting cell [type ii glomus cell]
    ¹öÆÀ¼¼Æ÷
  • swaged cast type crown
    ¾ÐÀÎÇü±Ý°ü(äâìÔû¡ ÐÝή).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ).
  • sympathicotonic type
    ±³°¨½Å°æ±äÀåÇü(¡­ÑÌíåúþ)
  • thinking type
    »ç°íÇü(ÞÖÍÅúþ).
  • triaxone type
    »ïÃàÇü(ß²õîúþ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆÑÛ).
  • tuberculoid (type) leprosy
    À¯°áÇÙ³ª(׾̿ú·ÑÛ), °áÇپ糪(Ì¿ú·åÆ )
  • type A behavior
    AÇü Çൿ(ú¼ÔÑ).
  • type A encephalitis
    ±â¸é¼º ³ú¿°(ÐîØùàõÒàæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
SFB Sanfilippo syndrome type B; saphenofemoral bypass; surgical foreign body
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
WSI Waardenburg syndrome type I
ADS acute death syndrome; acute diarrheal syndrome; Alcohol Dependence Scale; alternative delivery syste...
AIS Abbreviated Injury Scale; amniotic infection syndrome; androgen insensitivity syndrome; anterior int...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
11 beta-HSD-1 11 beta-Hydroxysteroid dehydrogenase type 1
11 beta-HSD2 11 beta-Hydroxysteroid dehydrogenase type 2
5-HT3 5-hydroxytryptamine type 3
ANP A type natriuretic peptide
AT1 A-II type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cervical fusion syndrome
    °æºÎ À¯ÇÕ ÁõÈıº
  • cervicobrachial syndrome
    °æ »ó¿Ï ÁõÈıº
  • Cestans syndrome
    ¼¼½ºÅº ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµå ÁõÈıº
  • chiasmal syndrome
    ½Ã ½Å°æ ±³Â÷ºÎ ÁõÈıº
  • Chilaiditis syndrome
    ų¶óÀÌµðÆ¼ ÁõÈıº
    °áÀå ¶Ç´Â ¼ÒÀåÀÇ ÀϺΰ¡ °£°ú Ⱦ°æ¸· »çÀÌ¿¡ °¨µ·ÇÏ¿© ÀϾ´Â ÁõÈıº.
  • cholecysto-hepatic flexure adhesion syndrome
    ´ã³¶ °áÀå °£°îºÎ À¯Âø ÁõÈıº
  • Chotzen's syndrome
    ÄÚþ ÁõÈıº
    ÷µÎÇÕÁöÁõÀ» ³ªÅ¸³»´Â »ó¿°»öü¼º ¿ì¼ºÀ¸·Î À¯ÀüµÇ´Â À¯Àü¼º Áúȯ.
  • chromaosomal breakage syndrome

    chromate

    Á¦ 2Å©·Ò»ê¿°
    1. Á¦2 Å©·Ò»êÀÇ ¸ðµç ¿°. 2. Á¦2Å©·Ò»ê¿° ¼ö¿ë¼ºÀÇ. Á¦2Å©·Î»ê¿°ÀÇ ÀÛ¿ëÀ» ½±°Ô ¹Þ¾ÆµéÀÌ´Â. 3. Å©·Ò»ê¿°.
  • chromosomal syndrome
    ¿°»öü ÁõÈıº
  • chromosome longarm deletion syndrome
    ¿°»öü ÀåÁö °á¼Õ ÁõÈıº
  • chromosome-breakage syndrome
    ¿°»öü-ºÐÇØ ÁõÈıº
  • chronic fatigue syndrome
    ¸¸¼º ÇÇ·Î ÁõÈıº
    ½±°Ô ÇǰïÇϰí ÁöÄ¡¸ç ¸öÀÌ ³ª¸¥ÇØÁö´Â µîÀÇ ÇÇ·Î Áõ¼¼°¡ 6°³¿ù ÀÌ»ó ¸¸¼ºÀûÀ¸·Î Áö¼ÓÇÏ´Â Áõ»ó. È®½ÇÇÑ ¿øÀÎÀº ¹àÇôÁ® ÀÖÁö ¾Ê°í, ¹ÙÀÌ·¯½º °¨¿°ÀÌ ±× ¿øÀÎÀÇ Çϳª·Î ÃßÁ¤µÈ´Ù. Æò¼Ò °Ç°­ÇÑ »ç¶÷¿¡°Ô¼­ °¨±â³ª ¸ö»ì ±â¿îÀÌ ÀÖ´Ù°¡ ÀÌ·± ÇǷΰ¡ ³ªÅ¸³­´Ù. ´ëü·Î Ưº°ÇÑ Ä¡·á°¡ ÇÊ¿ä¾øÀÌ ÀúÀý·Î Ä¡À¯µÇ³ª ÇǷθ¦ ´À³¢°Ô ÇÏ´Â ´Ù¸¥ Áúº´ÀÇ À¯¹«¸¦ È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. ƯÈ÷ ½ºÆ®·¹½º, ¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö µî°ú °°Àº Á¤½ÅÀû ¹®Á¦°¡ ¾à 50 %¸¦ Â÷ÁöÇϸç, ½ÅüÀû ÁúȯÀ¸·Î´Â ´ç´¢º´, °©»ó¼± Áúȯ, ¸¸¼º È£Èí±â Áúȯ, ºóÇ÷, °áÇÙ, °£¿°, ½ÅÀå ÁúȯÀ̳ª ¾Ï µî¿¡ ÀÇÇØ¼­µµ ¸¸¼ºÀû ÇǷΰ¨À» ´À³¥ ¼ö ÀÖ´Ù. ÀÌ¿Í °°Àº ÁúȯÀÌ ¾ø´Â °ÍÀÌ ÆÇ¸íµÇ¸é ¸¸¼º ÇÇ·Î ÁõÈıºÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖ´Ù.
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺαº
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³ú ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
interferon type I <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
interferon type II <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
ocean-type fish An anadromous fish that shows no indication on its scales or other hard parts of an extended freshwater residence early in its life.
(09 Oct 1997)
Ellis type 1 glomerulonephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 1 nephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 2 glomerulonephritis An obsolete designation for glomerulonephritis which is usually not related to preceding bacterial infection; characterised by an insidious onset of the nephrotic syndrome, failure of complete remission, and eventual development of chronic renal failure. The kidneys usually show membranous glomerulonephritis.
Synonym: Ellis type 2 nephritis.
(05 Mar 2000)
Ellis type 2 nephritis An obsolete designation for glomerulonephritis which is usually not related to preceding bacterial infection; characterised by an insidious onset of the nephrotic syndrome, failure of complete remission, and eventual development of chronic renal failure. The kidneys usually show membranous glomerulonephritis.
Synonym: Ellis type 2 nephritis.
(05 Mar 2000)
Ellis type II <nephrology> A type of nephritis that is characterised by low serum albumin, large amount of protein in the urine and swelling (oedema). Swelling, weight gain, high blood pressure and anorexia are key features. Nephrotic syndrome can be seen with a number of illness that cause damage to the kidney glomerulus.
Examples include diabetes, hereditary disorders, lupus, multiple myeloma, amyloidosis, glomerulonephritis, minimal change disease and membranous glomerulonephritis.
(27 Sep 1997)
erotomanic type of paranoid disorder The false belief that one is loved by another such as a movie star or a casual acquaintance.
(05 Mar 2000)
tuberculin-type hypersensitivity A local or generalised response that begins 24 to 48 hours after exposure to an antigen.
See: cell-mediated reaction.
Synonym: contact hypersensitivity, delayed hypersensitivity, late reaction, tuberculin-type hypersensitivity.
(05 Mar 2000)
jealous type of paranoid disorder The false belief that one's spouse or lover is unfaithful and leading to repeated confrontation, or the taking of extraordinary steps to intervene in the imagined infidelity.
(05 Mar 2000)
type 1. The mark or impression of something; stamp; impressed sign; emblem.
2. Form or character impressed; style; semblance.
3. A figure or representation of something to come; a token; a sign; a symbol; correlative to antitype.
4. That which possesses or exemplifies characteristic qualities; the representative.
<biology> Specifically: A general form or structure common to a number of individuals; hence, the ideal representation of a species, genus, or other group, combining the essential characteristics; an animal or plant possessing or exemplifying the essential characteristics of a species, genus, or other group. Also, a group or division of animals having a certain typical or characteristic structure of body maintained within the group.
<chemistry> A simple compound, used as a mode or pattern to which other compounds are conveniently regarded as being related, and from which they may be actually or theoretically derived.
The fundamental types used to express the simplest and most essential chemical relations are hydrochloric acid, HCl; water, H2O; ammonia, NH3; and methane, CH4.
5. A raised letter, figure, accent, or other character, cast in metal or cut in wood, used in printing. Such letters or characters, in general, or the whole quantity of them used in printing, spoken of collectively; any number or mass of such letters or characters, however disposed.
Origin: F. Type; cf. It. Tipo, from L. Typus a figure, image, a form, type, character, Gr. The mark of a blow, impression, form of character, model, from the root of to beat, strike; cf. Skr. Tup to hurt.
Source: Websters Dictionary
(01 Mar 1998)
type 1 dextrocardia Displacement of the heart to the right side of the chest with mirror transposition of the cardiac chambers together with transposition of the abdominal viscera.
Synonym: type 1 dextrocardia.
(05 Mar 2000)
type 1 diabetes <endocrinology> Also referred to as juvenile onset diabetes. Underlying cause is likely genetic. Usually treated with daily insulin dosing. Insulin is necessary for the body to properly utilise glucose. Without insulin, glucose accumulates in the bloodstream.
(27 Sep 1997)
type 1 glycogenosis Glycogenosis due to glucose-6-phosphatase deficiency, resulting in accumulation of excessive amounts of glycogen of normal chemical structure, particularly in liver and kidney.
Synonym: Gierke's disease, glucose-6-phosphatase hepatorenal glycogenosis, von Gierke's disease.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á